1 / 19

IVM is ready as a treatment for PCOS patients

IVM is ready as a treatment for PCOS patients. Dr. Milton Leong MDCM DSc (McGill) Director, IVF Center , HKSH Adjunct Professor, OBS-GYN, McGill University. PCOS. Commonest endocrine disorder in women May be 80% anovulatory infertility? Ovulation induction required

kana
Télécharger la présentation

IVM is ready as a treatment for PCOS patients

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. IVM is ready as a treatment for PCOS patients Dr. Milton Leong MDCM DSc (McGill) Director, IVF Center, HKSH Adjunct Professor, OBS-GYN, McGill University

  2. PCOS • Commonest endocrine disorder in women • May be 80% anovulatory infertility? • Ovulation induction required • Most are clomiphene responsive • Cumulative pregnancy rates lower than non-PCOS patients • Balen 2002 2004

  3. PCOS • Ovulation Induction: • Low dose - reduced response • Higher dose - over-response • Leading to multiple pregnancies • Higher risk OHSS

  4. PCOS and IVF • IVF is an effective, may be preferred choice of therapy because of the problems associated with ovulation induction • Significantly more oocytes • Lower fertilization rate • Dor et al, Homburg et al Kodama et al

  5. PCOS and IVF • Pregnancies were comparable to non-PCOS patients • Increased miscarriage rate • FSH requirement leads to under or over response • Higher cancellation rate • Much higher chance of OHSS

  6. PCOS, OHSS and IVF • Risk up 5-30 fold (6-30%) • Estradiol >3000pg/ml • # Follicles >20

  7. OHSS in PCOS Undergoing IVF • Preventive Measures: • Pre-treat with laparoscopic drilling • Use GnRH-ant then GnRH-a to trigger • Metformin (as short as 28 days) • No Transfer, Cryopreservation • Early Aspiration of Follicles - 2 operations • Conversion to IVM • IVM with and/or without stimulation

  8. Progress in IVM • Edwards 1965 : 1st in vitro matured oocyte • Veeck 1983 : 1st IVM pregnancy from an ovum derived from a • stimulated cycle • Cha et al. 1991 : the first pregnancy from in-vitro matured oocytes derived from a caesarean section donor • Trounson et al. 1994: IVM in women with PCOS • improvements in culture condition and transfer techniques have demonstrated that IVM is an effective treatment for women with PCO or PCOS. • In general, clinical pregnancy and implantation rates for infertile women with PCO or PCOS have reached approximately 30-35% and 10-15%, respectively, (Chian et al., 2004).

  9. Advantages of IVM • No/minimal stimulation: less OHSS less long term effect safety factor – cancer patients • Flexible start time, no preparation • Cancer patients no theoretical and actual risk (esp br ca) can treat anytime

  10. IVM/IVF vs IVF for PCOS Child TJ, et al,2002

  11. IVM-IVF in POS 210 cycles 1883 oocytes 56% maturation 83% fertilization Pregnancy rate 31% fresh 32% frozen-thawed 50/56 pregnancies delivered Miscarriage 11% OHSS 0% A. Fukuda et al, Fertility & Sterility 2008

  12. Ovulation trigger LH surge induced by GnRH agonist achieves identical clinical outcome as HCG in in vitro maturation, in vitro fertilization and embryo transfer (IVM-IVF)

  13. GnRHav.s. HCG in IVF-IVF used in PCOS 300 ųg Buserelin vs 10000 unit HCG Maturation rate same (±50%) Fertilization rate same 85% Pregnancy rate same 41% OHSS rate < 1% A. Fukuda et al, Fertility and Sterility 2008

  14. Pregnancy Outcome in IVM Malformation: Cha, Fertil. Steril. 2005 5,3% major malformation rate Later neuromotor development: Soderstrom-Anttila, Hum. Reprod. 2006 ))) Minor developmental delay at first year ))) No Difference in the second year

  15. Known live deliveries from IVM/IVF

  16. McGill IVM results by age group (own oocytes only – patients with PCO or PCOS)

  17. Results of IVM from Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan* Cycles 68 Age 31.3 ± 4.1 No. of oocytes collected 1,528 (21.9 ± 9.4) % of oocyte maturation 72.5% % of fertilization 75.8% % of cleavage 89.4% Mean of embryos transferred 3.8 ± 0.9 No. of clinical pregnancies (%) 23 (33.8) % of implantation 11.3% % of OHSS <1% * Data from Dr. Lin & Dr. Hwang (2003)

  18. IVM/IVF in PCOS Conclusions: PCOS is associated with OHSS OHSS = 80% post EC hospital admissions IVM/IVF is an established clinical technique IVM/IVF can reduce incidence of OHSS IVM/IVF can now be the treatment of choice for PCOS in IVF

More Related